Skip to Content

Analytical Chemistry on Complex Drug Analysis

Oak Ridge Associated University, Silver Spring, Maryland

Position Description:

A research opportunity is available in the Office of Pharmaceutical Quality/Office of Testing and Research, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) located in Silver Spring, Maryland.

The Center for Drug Evaluation and Research (CDER) performs an essential public health task by making sure that safe and effective drugs are available to improve the health of people in the United States. As part of the U.S. Food and Drug Administration (FDA), CDER regulates over-the-counter and prescription drugs, including biological therapeutics and generic drugs. This work covers more than just medicines.

The project in the Office of Pharmaceutical Quality/Office of Testing and Research will support complex generic/biosimilar product approval through developing robust high resolution Nuclear Magnetic Resonance (NMR) methods to characterize complex drug products. The complex analysis may include, but will not be limited to, protein higher order structure (HOS) and polysaccharide composition determination.

Under the guidance of the mentor, the participant will learn about high field NMR, dynamic light scattering, fast protein liquid chromatography, and complex data analysis.

This program, administered by Oak Ridge Associated University (ORAU) through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program.

Disclaimers:

Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.

Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA.  OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.

FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency. This agreement covers such topics as the following:
  • Non-employee nature of the ORISE appointment;
  • Prohibition on ORISE Fellows performing inherently governmental functions;
  • Obligation of ORISE Fellows to convey all necessary rights to the FDA regarding intellectual property conceived or first reduced to practice during their fellowship;
  • The fact that research materials and laboratory notebooks are the property of the FDA;
  • ORISE fellow’s obligation to protect and not to further disclose or use non-public information.

Qualifications:

The qualified candidate should be currently pursuing or have received a doctoral degree in one of the relevant fields. Degree must have been received within the past five years.

Preferred skills:
  • Strong analytical experience
  • Knowledge with chemical composition analysis of polysaccharides or structure characterization of proteins

To Apply:

For more information and to apply, please visit https://www.zintellect.com/Opportunity/Details/FDA-CDER-2021-0688.

Application deadline: Nov. 30, 2021